Related Experiment Videos
Compliance and therapeutic issues in resistant depression
1Department of Psychiatry, University Clinics of Brussels, Erasmus Hospital, Free University of Brussels, Belgium.
International Clinical Psychopharmacology
|July 21, 1998
Summary
Many depressed patients don't respond to standard treatment, but non-compliance might inflate "treatment-resistant depression" rates. Optimizing patient adherence is key for effective depression management.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Up to 30% of depressed patients show poor response to standard antidepressant pharmacotherapy.
- Surveys indicate inappropriate treatment in 25% of depressed patients.
- Patient non-compliance may account for 20% of treatment-resistant cases, potentially overestimating the true resistance rate.
Purpose of the Study:
- To review factors influencing treatment-resistant depression (TRD).
- To emphasize the role of patient compliance in TRD.
- To explore strategies for optimizing compliance in TRD management.
Main Methods:
- Comprehensive literature review.
- Analysis of treatment aspects and patient characteristics in TRD.
- Examination of factors affecting treatment response and compliance.
Main Results:
- Key factors in TRD include elevated pharmacotherapy doses, long treatment durations, and treatment tolerance.
- Disease severity, Axis I/II comorbidities, and chronic disorders are significant patient variables.
- These variables also impact patient compliance, highlighting its critical role.
Conclusions:
- The prevalence of TRD may be overestimated due to non-compliance.
- Patient compliance is a crucial factor throughout all treatment phases for TRD.
- Strategies to improve compliance are vital for effective TRD management.